Companies / SolasCure
SolasCure
Cambridge, United Kingdom
SolasCure is developing Aurase Wound Gel, a biologic designed to debride and drive healing of chronic wounds.
SolasCure, based in Cambridge, United Kingdom, has 2 investors on file, among them Bionova Capital and Seneca Growth Capital VCT. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
More from Bionova Capital
14 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (44%), Fintech (22%), Gaming (11%).
See Bionova Capital's full profile · Who invests alongside it
More from Seneca Growth Capital VCT
13 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (41%), E-commerce & Marketplaces (12%), Education (12%).
See Seneca Growth Capital VCT's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get SolasCure and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Bionova Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/solascure.com/investors
# also
GET /v1/companies/solascure.com
GET /v1/companies/solascure.com/news